Centene Will Be Presenting At The Wells Fargo 2023 Healthcare Conference Today. The Company Reaffirms Its Previously Issued 2023 Adjusted Eps Guidance Of At Least $6.45 Vs. Consensus Of $6.5 And 2024 Adjusted EPS Of Over $6.60 Versus Consensus Of $6.69
Portfolio Pulse from Benzinga Newsdesk
Centene Corporation will be presenting at the Wells Fargo 2023 Healthcare Conference today. The company reaffirms its previously issued 2023 adjusted EPS guidance of at least $6.45, slightly below the consensus of $6.5. It also maintains its 2024 adjusted EPS guidance of over $6.60, again slightly below the consensus of $6.69.
September 06, 2023 | 10:22 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Centene's reaffirmation of its 2023 and 2024 adjusted EPS guidance, which is slightly below consensus, may have a neutral to slightly negative impact on its stock in the short term.
Centene's reaffirmation of its EPS guidance, which is slightly below consensus, may cause some investors to adjust their expectations downwards. This could put some downward pressure on the stock price in the short term. However, the fact that the company is maintaining its guidance suggests that it is confident in its ability to meet these targets, which could mitigate some of this negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100